These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of disorders of lipid metabolism with the new lipid regulator X50].
    Author: Reuter W, Herrmann W, Sauer I, Janowski K, Dorn H, Steinicke A.
    Journal: Z Gesamte Inn Med; 1986 Mar 01; 41(5):124-6. PubMed ID: 3754999.
    Abstract:
    With the newly developed lipid regulant X 50 = 1-benzyl-3-(1-carboxyl-methylethoxy)-4-methylpyrazol 15 patient with primary hypercholesterolaemia and hypertriglyceridaemia were treated for 3 months. A significant decrease of the serum triglycerides by 47% in all patients and of the total cholesterol by 32% in half the patients (LDL cholesterol decrease 25%) was the result. Altogether an increase of the linoleic acid of 14% and a decrease of the uric acid of 16% were furthermore the result. There were practically no side effects.
    [Abstract] [Full Text] [Related] [New Search]